MAGEB10 and mesenchymal cell neoplasm: Additionally, the proportion of MAGE-B10 mRNA expression was highest in carcinosarcomas, followed by epithelial neoplasms and mesenchymal neoplasms, with a proportion of 100.0% (3/3), 68.4% (13/19), and 50% (1/2), respectively.